Resources to Advance Pediatrics and HIV Prevention Science
Active Master IDIQ Awarded
- Federal agency
-
National Institute of Allergy and Infectious Diseases
- Awardees
- 4
- Task orders
- 14
- Obligated
- $17,541,771
Vehicle facts
- Opportunity
-
- Resources to advance pediatrics and HIV prevention science Pre-Solicitation · 75N93021R00020 · Posted Feb 18, 2022
- Agency
-
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- Combined task order value
-
- $17,541,771 Current, with exercised options
- $34,206,096 Potential, with all options
- Last date to order 50% complete
- Shared ceiling 18% used
- $98,878,757.00
IDV award and task order details come from SAM.gov/FPDS.
About this vehicle
The National Institute of Allergy and Infectious Diseases is operating a master IDIQ established April 15, 2023, to procure preclinical development support services for HIV, pediatric, and prevention products, with ordering authority extending through April 14, 2030. The vehicle carries a shared ceiling of $98.9 million and includes no set-aside restrictions.
Ordering momentum has slowed modestly. The vehicle generated 7 task orders in 2023 and 5 in 2024, with the most recent award issued September 1, 2024. Of the $29 million combined potential value across 12 task orders, $10.3 million (36%) has been obligated, leaving substantial room for future orders within the ceiling.
Work is heavily concentrated on pediatric drug formulation and development support. Recent task orders span bitter taste receptor blockers for palatability improvement (ceiling values of $3.8 million and $2.4 million), professional pharmaceutical project management ($6.1 million ceiling), expertise in pediatric formulation development ($4.1 million ceiling), AI/ML enhancement of the STEP pediatric excipient database ($1.2 million), product development lifecycle services ($4.3 million ceiling), quality assurance and control support ($6.2 million ceiling), and logistics support ($484 thousand ceiling). All awards carry Cost Plus Fixed Fee or Cost No Fee pricing. Typical task-order ceilings range from roughly $250 thousand to $6 million, with durations extending from one to six years.
Advanced Bioscience Laboratories, Inc. dominates the vehicle with 9 of 12 awarded orders representing $28.9 million of the $29 million combined potential value. Three other primes—Sri International, The Administrators Of Tulane Educational Fund, and Lovelace Biomedical Research Institute—hold the remaining orders with negligible combined value. All task orders fund the National Institute of Allergy and Infectious Diseases.
IDV awards
Latest task orders
Show all 14
Top awardees by obligations
| Rank | Awardee | Obligated | Share |
|---|---|---|---|
| 1 | Advanced Bioscience Laboratories, Inc. | $17,454,930 | 100% |
| 2 | Sri International | $45,041 | <1% |
| 3 | The Administrators Of Tulane Educational Fund | $21,632 | <1% |
| 4 | Lovelace Biomedical Research Institute | $20,168 | <1% |
"Minimum guarantee only" marks awardees whose obligations here are just the minimum order their contract guarantees.
Top funding agencies by obligations
| Rank | Funding agency | Obligated | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $17,541,771 | 100% |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2026 | $7,870,573 |
| FY2025 | $2,703,849 |
| FY2024 | $5,893,562 |
| FY2023 | $1,073,787 |
Quick answers
What is the Resources to Advance Pediatrics and HIV Prevention Science contract vehicle?
Resources to Advance Pediatrics and HIV Prevention Science is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by National Institute of Allergy and Infectious Diseases (National Institutes of Health), awarded on April 15, 2023.
Which companies hold Resources to Advance Pediatrics and HIV Prevention Science?
4 companies hold Resources to Advance Pediatrics and HIV Prevention Science's IDV awards, one each. The latest went to Advanced Bioscience Laboratories, Inc. on April 15, 2023. The awardees whose task orders obligated the most are Advanced Bioscience Laboratories, Inc., Sri International and The Administrators Of Tulane Educational Fund.
How much has been spent through Resources to Advance Pediatrics and HIV Prevention Science?
14 task orders have been placed under Resources to Advance Pediatrics and HIV Prevention Science, obligating $17,541,771.
What is the shared ceiling of Resources to Advance Pediatrics and HIV Prevention Science?
Resources to Advance Pediatrics and HIV Prevention Science's shared ceiling is $98,878,757; its task orders have used 18% of it.
Which agencies use Resources to Advance Pediatrics and HIV Prevention Science the most?
The departments whose task orders under Resources to Advance Pediatrics and HIV Prevention Science obligated the most are Department of Health and Human Services ($17,541,771).
How much was obligated through Resources to Advance Pediatrics and HIV Prevention Science in fiscal year 2025?
Task orders under Resources to Advance Pediatrics and HIV Prevention Science obligated $2,703,849 in fiscal year 2025.
On GovTribe
See this vehicle's full record
- Every IDV award and task order
- Funding by agency, awardee, NAICS and set-aside
- Teaming partners on this vehicle
- Ask GovTribe AI about this vehicle